Quick Answer
ONCOLYTICS BIOTECH INC reported Earnings Per Share Diluted of $0.30 (loss) per share for the year ending 2025.
- ONCOLYTICS BIOTECH INC showed an increase of +0.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from ONCOLYTICS BIOTECH INC's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $0.30 (loss) per share | Fiscal year 2024: $0.30 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: